Get the Stockscreener App
523.99
0.35%
-1.82
Pre-market:
522.41
-1.58
-0.30%
Intuitive Surgical Inc stock is traded at $523.99, with a volume of 2.80M.
It is down -0.35% in the last 24 hours and down -9.24% over the past month.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
See More
Previous Close:
$525.81
Open:
$530
24h Volume:
2.80M
Relative Volume:
1.38
Market Cap:
$185.75B
Revenue:
$10.06B
Net Income/Loss:
$2.88B
P/E Ratio:
66.49
EPS:
7.8807
Net Cash Flow:
$2.27B
1W Performance:
-2.06%
1M Performance:
-9.24%
6M Performance:
+4.39%
1Y Performance:
-13.91%
1-Day Range:
$521.18
$540.00
1-Week Range:
$518.64
$540.00
52-Week Range:
$425.00
$609.08
Intuitive Surgical Inc Stock (ISRG) Company Profile
Name
Intuitive Surgical Inc
Sector
Industry
Phone
(408) 523-2100
Address
1020 KIFER ROAD, SUNNYVALE
Compare ISRG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
523.99 | 186.40B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
201.79 | 58.70B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.29 | 39.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
46.00 | 38.25B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
252.38 | 37.27B | 5.26B | 1.44B | 1.76B | 9.7713 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-23-25 | Downgrade | Erste Group | Buy → Hold |
| Jun-09-25 | Downgrade | Deutsche Bank | Hold → Sell |
| Jun-05-25 | Upgrade | Erste Group | Hold → Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-02-24 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Nov-17-23 | Initiated | HSBC Securities | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-19-23 | Reiterated | BTIG Research | Buy |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Evercore ISI | In-line |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Morgan Stanley | Equal-Weight |
| Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-19-23 | Reiterated | Raymond James | Outperform |
| Apr-19-23 | Reiterated | Stifel | Buy |
| Apr-19-23 | Reiterated | Truist | Buy |
| Apr-19-23 | Reiterated | Wells Fargo | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-23-23 | Initiated | William Blair | Outperform |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-13-22 | Initiated | Mizuho | Neutral |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-25-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-25-22 | Downgrade | Redburn | Buy → Neutral |
| Jan-21-22 | Reiterated | BTIG Research | Buy |
| Jan-21-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Evercore ISI | In-line |
| Jan-21-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-21-22 | Reiterated | Piper Sandler | Neutral |
| Jan-21-22 | Reiterated | Raymond James | Outperform |
| Jan-21-22 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Reiterated | UBS | Neutral |
| Jan-21-22 | Reiterated | Wells Fargo | Overweight |
| Jan-10-22 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Jul-21-21 | Reiterated | BofA Securities | Neutral |
| Jul-21-21 | Reiterated | Citigroup | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Jul-21-21 | Reiterated | Piper Sandler | Neutral |
| Jul-21-21 | Reiterated | SVB Leerink | Mkt Perform |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jul-21-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Reiterated | Wells Fargo | Overweight |
| Jul-14-21 | Reiterated | Goldman | Buy |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Apr-21-21 | Upgrade | Oppenheimer | Underperform → Perform |
| Apr-21-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Dec-15-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-28-20 | Initiated | Argus | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jul-20-20 | Reiterated | Bernstein | Outperform |
| Apr-28-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-17-20 | Downgrade | CFRA | Hold → Sell |
| Apr-17-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-09-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
| Jan-27-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-19 | Reiterated | Wells Fargo | Outperform |
| Nov-21-19 | Initiated | Oppenheimer | Perform |
| Jul-19-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-22-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-02-19 | Initiated | Deutsche Bank | Buy |
| Oct-31-18 | Reiterated | Piper Jaffray | Overweight |
| Oct-19-18 | Upgrade | Canaccord Genuity | Hold → Buy |
View All
Intuitive Surgical Inc Stock (ISRG) Latest News
The da Vinci is here; Robotic-assisted surgery is now available in Le Mars - nwestiowa.com
Beyond Biotech-3 Healthcare Stocks for Growth-Minded Investors - Finviz
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors - MarketBeat
Whittier Trust Co. of Nevada Inc. Boosts Holdings in Intuitive Surgical, Inc. $ISRG - MarketBeat
Whittier Trust Co. Buys 7,128 Shares of Intuitive Surgical, Inc. $ISRG - MarketBeat
Robocap Asset Management Ltd Purchases 3,109 Shares of Intuitive Surgical, Inc. $ISRG - MarketBeat
UniSuper Management Pty Ltd Sells 51,278 Shares of Intuitive Surgical, Inc. $ISRG - MarketBeat
Simplicity Wealth LLC Has $707,000 Stake in Intuitive Surgical, Inc. $ISRG - MarketBeat
Cullen Frost Bankers Inc. Buys 3,450 Shares of Intuitive Surgical, Inc. $ISRG - MarketBeat
CIBC Asset Management Inc Grows Stake in Intuitive Surgical, Inc. $ISRG - MarketBeat
AMF Tjanstepension AB Sells 39,464 Shares of Intuitive Surgical, Inc. $ISRG - MarketBeat
Intuitive Surgical stock slips into weekend after earnings beat, with tariffs and 2026 outlook in focus - TechStock²
Baird reaffirms buy on Intuitive Surgical (ISRG) after new FDA clearances - MSN
Rockport Wealth LLC Grows Position in Intuitive Surgical, Inc. $ISRG - MarketBeat
Symphony Financial Ltd. Co. Lowers Position in Intuitive Surgical, Inc. $ISRG - MarketBeat
Y Intercept Hong Kong Ltd Acquires New Stake in Intuitive Surgical, Inc. $ISRG - MarketBeat
Mn Services Vermogensbeheer B.V. Acquires 2,300 Shares of Intuitive Surgical, Inc. $ISRG - MarketBeat
Resona Asset Management Co. Ltd. Grows Stock Position in Intuitive Surgical, Inc. $ISRG - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Increases Stock Position in Intuitive Surgical, Inc. $ISRG - MarketBeat
Intuitive Surgical, Inc. (NASDAQ:ISRG) Q4 2025 Earnings Call Transcript - Insider Monkey
Jennison Associates LLC Sells 235,012 Shares of Intuitive Surgical, Inc. $ISRG - MarketBeat
Intuitive Surgical, Inc. $ISRG Shares Sold by Baillie Gifford & Co. - MarketBeat
3 Troubling Trends for Intuitive Surgical – and 1 Bright Spot - Yahoo Finance
This Robotic Surgery Pioneer Could Be Worth $1 Million for Long-Term Holders - AOL.com
Truist Securities reiterates Buy rating on Intuitive Surgical stock By Investing.com - Investing.com South Africa
Intuitive Eyes Opportunities In Cardiac Care, Outpatient Centers - Citeline News & Insights
Intuitive Surgical Earnings Call: Growth Surges, Margins Pinched - TipRanks
AI Bubble or Sustainable Growth? Here Are 2 Healthcare Companies Harnessing AI for the Long Term. - Yahoo Finance
Intuitive Surgical Milestones Test Valuation As Cardiac Robotics Opportunities Grow - simplywall.st
Stifel reiterates Buy rating on Intuitive Surgical stock after strong Q4 - Investing.com Nigeria
Why This Robotics Giant's Lackluster Guidance Isn't All Doom - Investor's Business Daily
Intuitive’s da Vinci 5 Secures FDA Cardiac Clearance - Medical Device and Diagnostic industry
ISRG: Intuitive Surgical (NASDAQ) $524.09 intraday 23 Jan 2026: Model 15.62% upside - Meyka
Intuitive Surgical (ISRG) Analyst Rating and Price Target Update: January 2026 | ISRG Stock News - GuruFocus
Healthcare Stocks To Keep An Eye OnJanuary 23rd - MarketBeat
ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines - The Globe and Mail
Intuitive Surgical reports strong Q4 results; sees slower da Vinci procedure growth in FY26 - AlphaStreet
Intuitive Surgical Inc (NASDAQ:ISRG) Surpasses Analysts’ Expectations - FXDailyReport.Com
Intuitive pushes into cardiac robotic surgery, ASCs - MedTech Dive
Intuitive Surgical receives FDA clearance for non-force feedback instruments in cardiac procedures - Medical Device Network
Intuitive Surgical Just Proved the Growth Engine Still Runs - MarketBeat
ISRG Q4 Deep Dive: New Product Launches and International Growth Drive Results - Finviz
Intuitive Surgical’s JURA Feasibility Study: Early Imaging Data With Long-Term Upside for Investors - TipRanks
Intuitive Surgical's Strong Earnings and Future Growth Prospects - GuruFocus
Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. - Barron's
Intuitive Surgical Tops Expectations as Robotic Surgeries See Massive Surge - Sahm
Intuitive Surgical Q4 2025 Earnings: Profit & Revenue Beat ForecastsNews and Statistics - IndexBox
Intuitive Surgical (ISRG) Surpasses 20 Million Da Vinci Procedures Globally - GuruFocus
2 Healthcare Names That Could Get a Big Boost From Earnings - Investing.com
Truist Securities reiterates Buy rating on Intuitive Surgical stock - Investing.com
Raymond James Financial Raises Intuitive Surgical (NASDAQ:ISRG) Price Target to $615.00 - MarketBeat
Intuitive Surgical Inc Stock (ISRG) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.06%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):